Company Data
Kineta Inc.
Overview
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients’ lives. The company’s lead asset is KVA12.1, a VISTA blocking immunotherapy.
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients’ lives. The company’s lead asset is KVA12.1, a VISTA blocking immunotherapy.